semaglutide injections surprise Beyond Weight Loss: How the 'Blockbuster' Drug Could Finally Break Alcohol Addiction 5 Surprising Facts About Ozempic

Nonalcoholic fatty liver disease (NAFLD) is a prevalent metabolic liver disease closely associated with the epidemics of obesity and type 2 diabetes mellitus (T2DM), but without licensed pharmacological treatment to date

Inspira Health offers personalized guidance to help you find the right GLP-1 option for your goals and lifestyle.

Injectable GLP-1 Medications: What to Know on NewBeauty Expert beauty insights, trends, and treatments across skincare and aesthetics to help you look and feel your best.

Forecasting models often overestimate ROI: Many commercial forecasts fail to account for patient leakage, especially in obesity indications, leading to inflated expectations and missed market realities

Two recently developed methods for visually presenting complex weight and health-risk information that encapsulate substantial amounts of clinical trial observations were recently developed that can potentially supplement and give new insights into conventional GLP-1R agonist scientific reports

Some Americans are turning to a group of diabetes medications for something other than relief from the disease